Insulin Lawsuit News and Information
Medtronic Infusion Set Recall Insulin Pump Lawsuits
Insulin pump manufacturer Medtronic Inc. has issued a recall of approximately three million Quick-set infusion sets for its MiniMed Paradigm insulin pumps due to a manufacturing defect that could result in the delivery of incorrect doses of insulin. This may cause serious injury or death for diabetics using the Medtronic insulin pumps.
All Articles Tagged With: "Insulin"
FDA Meeting Today to Review Mounting Problems with Insulin Pumps
A panel of outside advisers to the FDA are scheduled to meet today to review what steps the regulatory agency might take to reduce the risk of potentially serious problems for diabetics caused by insulin pumps. The FDA has noted a disturbing number of problems with insulin pumps, which are growing in popularity. [...]
OneTouch SureStep Test Strip Recall: May Provide Low Blood Glucose Levels
About 14,000 packages of OneTouch SureStep Test Strips, used to measure blood glucose levels in people with diabetes, have been recalled because they could provide incorrect information about blood glucose levels.
Nipro GlucoPro Insulin Syringe Recall: Needles May Come Out During Use
The FDA and Nipro Medical Corporation have announced a nationwide recall of all GlucoPro Insulin Syringes due to a risk that the needle may break off of the syringe during injection.
Accusure Insulin Syringe Recall: Needle May Detach from the Syringe
Two lots of Accusure insulin syringes have been recalled due to defective needles that can detach from the syringes during use, according to a notice posted by the FDA on Friday.
FDA Warns GDH-PQQ Glucose Test Strips May Lead to Serious Injury or Death
The FDA is warning diabetics to avoid using glucose test strips or meters relying on glucose dehydrogenase pyrroloquinoline quinone (GHD-PQQ) because the strips can give false readings that could lead the user to mistakenly take an insulin overdose.
Medtronic Paradigm Recall: Quick-Set Infusion Sets for MiniMed Insulin Pump
Medtronic Inc. has recalled three million disposable infusion sets designed for their MiniMed Paradigm insulin pumps after discovering that some of them could deliver incorrect doses of insulin, potentially leading to injury or death.
Lantus Cancer Risk Being Reviewed by FDA
The FDA is reviewing new information about potential Lantus cancer side effects after several observational studies were published that suggest the artificial insulin may be associated with an increased incidence of cancer. However, the agency has expressed doubts about whether a connection between the use of Lantus and cancer truly exists.
Lantus Insulin Side Effects Linked to Risk of Cancer: Study
New research suggests that side effects of Lantus, an artificial form of insulin manufactured by Sanofi-Aventis for diabetes, may increase the risk of developing cancer.
Hospitals Sharing of Insulin Pens and Cartridges May Have Exposed Patients to Risk of HIV, Hepatitis
Thousands of patients at two military hospitals are being notified that they may have been exposed to blood-borne pathogens that could cause diseases like hepatitis and HIV, as a result of sharing insulin pens and insulin cartridges which are only meant for single-patient use.
Contact a Lawyer
Submit information about your potential case to be reviewed by an attorney.
